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Sununary 
The proteasome is a 700-kD multisubunit enzyme complex with several proteolytically active 
sites. The enzyme complex is involved in both ubiquitin-dependent and -independent protein 
degradation and may contribute to the processing of antigens presented by major histocompatibility 
complex (MHC) class I molecules. Here we demonstrate that treatment of mouse fibroblast cells 
with 20 U interferon qr (IFN-y) for 3 d induces a change in the proteasome subunit composition 
and that the B-type subunit LMP2, which is encoded in the MHC class II region, is incorporated 
into the enzyme complex. This is paralleled by reduction of the homologous 6-subunit. IFN-3' 
stimulation  results  in  a  downregulation  of the chymotrypsin-like Suc-LLVY-MCA peptide 
hydrolyzing activity of 20S proteasomes whereas the trypsin-like activity remains unaffected. 
When tested as a substrate a synthetic 25-mer polypeptide whose sequence covers the antigenic 
nonapeptide YPHFMPTNL of the MCMV pp89, 20S proteasomes of IFN-3'-induced cells exhibit 
altered chymotrypsin-like cleavage site preferences. In the absence of IFN-qr induction, the naturally 
processed nonamer peptide that is presented by MHC class.I molecules appears as a minor cleavage 
product.  IFN-'y activation does not result in an increase of the final peptide but results in a 
different set of peptides. We hypothesize that these peptides represent precursor peptides that 
can be trimmed to final peptide size. 
T 
he proteasome is a nonlysosomal multisubunit 700-kD 
multicatalytic proteinase complex that possesses at least 
three distinct proteolytic sites with trypsin-like, chymotrypsin- 
like, and peptidyl-glutamyl-peptide hydrolyzing activity (1-3). 
The ubiquitous enzyme complex cleaves at neutral or slightly 
basic pH at the carboxy side of acidic, basic, and hydrophobic 
residues (for review see 4).  Recent work shows that there 
exist at least two additional proteolytically active sites, in- 
cluding one that is responsible for the initial cleavage of larger 
protein substrates degraded by 20S proteasomes (i.e., proteino- 
lytic site) (5). Since 20S proteasomes are not compartmental- 
ized they are thought to reside in the cytoplasm in an inac- 
tive  so-called  latent  state.  In  their  latent  conformation 
proteasomes are not able to cleave larger polypeptides or pro- 
teins  despite  the  fact  that  the peptidyl  cleavage  sites  are 
active (6). 
The proteasome is a cylinder-like particle composed of four 
staggered rings and it exhibits a six- to sevenfold symmetry 
(7, 8). Thus, eukaryotic proteasomes are built up of 24-28 
protein subunits with molecular masses between 35 and 21 
kD. Almost 20 different proteasomal cDNAs or genes from 
various species have been characterized that encode related 
protein subunits of the or- and B-type (9, 10). This nomen- 
clature is based on the similarity of the subunits to either 
the ot or B subunit of the archaebacteria proteasome (10). 
However, none of the subunits analyzed so far possess the 
sequence homologies to known proteinases. 
The importance of 20S proteasomes for various intracel- 
lular metabolic pathways has become evident from gene dis- 
ruption studies in yeast where all but one of an increasing 
number of proteasome deletion mutants  revealed  a lethal 
phenotype (9,  11). Mutational analysis also shows that the 
B-type subunits are involved in the generation of proteolyti- 
cally active sites, whereas the or-type subunits seem to be im- 
portant for assembly and the regulation of the complex (12). 
With regard to function, 20S proteasomes play a central role 
in ubiquitin-independent and, as part of a larger 26S com- 
plex, in ATP/ubiquitin-dependent intracellular protein turn- 
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proteasomes are involved in mitotic events and cell prolifera- 
tion (15, 16). 
At least two of the proteasome genes, encoding the pro- 
teasome 3-type subunits LMP2 and LMP7 map to the class 
II region of the MHC in close neighborhood to the peptide 
transporter genes (17-21).  The synthesis of these proteins is 
inducible by IFN-3, (19, 22,  23) and both subunits exhibit 
haplotype-dependent variations in their electrophoretic mo- 
bility. These results,  along with the fact that within a non- 
acidic environment 20S proteasomes cleave at the carboxy side 
of basic or hydrophobic residues, i.e., characteristics  thought 
to be required for MHC class I-related protein processing 
(24),  lead to the notion that the proteasome is the proteo- 
lytic enzyme responsible for generation of peptides presented 
by MHC class I molecules and this activity may implicate 
the function of ubiquitin-dependent proteolysis for at least 
some of the antigens (25). 
Recently the importance of LMP2/LMP7 and of the 20S 
proteasome itself was questioned as it was shown that func- 
tional peptide transporter genes (TAP) are sufficient to par- 
tially restore MHC class I antigen presentation in transformed 
human T2 cells (26, 27). Both LMP2 and LMP7 are nones- 
sential with regard to the basic enzymatic functions of 20S 
proteasome and viability of mammalian cells. Yet, their syn- 
thesis in response to IFN-3, may indicate a function of both 
subunits in the regulation of 20S proteasome. 
So far there exists no information about the role of LMP2 
and LMP7 within the proteasome complex and whether IFN-3, 
in fact influences proteasome activity at all. In the present 
communication we have analyzed the effect of IFN-y on 20S 
proteasome with regard to proteasomal subunit composition, 
enzyme activities, and polypeptide cleavage properties as well 
as the ability of the proteasome to produce antigenic pep- 
tides that are presented by MHC class I molecules. 
Materials and Methods 
Purification and Analysis of  20S Proteasome  Complexes.  All chro- 
matographic purification steps were performed at 4~  Mouse B7 
fibroblast cells were homogenized in KAc-buffer (80 mM KAc, 5 
mM MgAc2, 10 mM Hepes, pH 7.4) plus 0.1% Triton X-100 and 
the homogenate centrifuged at 40,000 g for 20 rain. The resulting 
sol-80 supernatant (28) was incubated with equilibrated DEAE- 
Sephacel mamx for 45 rain. Bound material was eluted with ex- 
traction buffer containing 500 mM KAc. The eluate was concen- 
trated with a filtration system (Amicon Corp., Danvers, MA) and 
subjected to centrifugation on 10-40% sucrose gradients in ex- 
traction buffer. Proteasome complexes were identified by enzyme 
assays using the fluorogenic substrate Suc-LLVY-MCA. 20S frac- 
tions revealing peptide hydrolyzing activity were pooled and ap- 
plied to fast performance liquid chromatography Mono Q column 
chromatography. 20S proteasome was eluted with a salt gradient 
between 0.1 and 1 M KC1 and identified by enzyme assays as de- 
scribed above. Analysis  of proteasome complexes  by SDS-PAGE (29), 
two-dimensional gel electrophoresis (30) were carried out as previ- 
ously described (28). 
Assay of Proteolytic Activity and HPLC Separation of Processed 
Peptides.  Purified  20S proteasome complexes were analyzed with 
regard to their peptide hydrolyzing activities using the fluorogenic 
peptide substrates Bz-VGR-MCA HC1 (trypsin-like), Suc-LLVY- 
MCA, and Suc-AAF-MCA (chymotrypsin-like) as described be- 
fore (31). 100 ng of purified 20S proteasome were used for kinetic 
studies. To assay  the polypeptide cleavage  properties we used a syn- 
thetic 25-met polypeptide (RLMYDM YPHFMPTNL GPSEKR- 
VWMS) whose sequence  was derived  from the murine cytomegalo- 
virus IE pp89 protein and that covers the antigenic nonamer region 
(32). 20/~g of polypeptide and 1/xg of proteasome in assay  buffer 
(20 mM Hepes/KOH,  pH 7.8, 2 mM MgAc2, 1 mM dithiothre- 
itol) were incubated at 37~  for 24 h. Incubations longer than 
24 h had no influence on the cleavage  products obtained￿9  The total 
volume was 300 #1. For analysis of the cleavage products, 50 #1 
of the assay  mix were applied to separation by HPLC chromatog- 
raphy. HPLC was performed on a reversed-phase column (Delta- 
Pac C18 150x3.9; Waters Associates, Milford, MA) using equip- 
ment from Pharmacia LKB (Piscataway, NJ). 25/zl of the digest 
was loaded and eluted with a flow rate of 1.0 ml/min in a linear 
acetonitrile gradient. Solution A: 20 mM ammonium acetate, pH 
6.5; solution B: 50% acetonitrile and 50% solution A. 0-4 min 
20~  B, 4-39 min linear increase to 90% B. 0.5-ml fractions were 
collected and stored at  -20~  or were directly subjected to the 
CTL assay. 
Sequencing the Complex Peptide  Mixture.  Peptide  sequencing was 
clone by Edman degradation on an instrument by Applied Bio- 
systems, Inc. (model 471A; Foster City, CA), 20/A digest was ap- 
plied on the sequencer and the received  data evaluated  by the chro- 
matography data system PEAKMASTER from Harley Systems 
(Buckinghamshire, UK). 
Cell Culture.  The mouse embryo fibroblast  cell  clone BALB.SV 
B7  (H-2  a)  originates  from  the  SV40-transformed  cell line 
BALB.SV (33). Pretreatment of cells with 20 U/ml recombinant 
murine IFN-3, (lot No. M3-RD48; kindly provided by Dr. G. R. 
Adolf, Bender Vienna, Vienna, Austria) was performed for 72 h. 
After trypsinization, cells were intensively washed, counted, and 
stored at  -70~  until use. 
Cytolytic Assay.  Ld-restricted and peptide-specific polyclonal 
CTL were generated by in vitro restimulation of spleen cells with 
the pp89-derived nonapeptide YPHFMPTNL (32) and priming of 
BALB/c (H-2  a) mice with the pp89 expressing recombinant vac- 
cinia virus MCMVielvacc. CTL were propagated by weekly pep- 
tide restimulations in the presence of recombinant human IL-2 (100 
U/ml).  As  target  cells, P815 (H-2  d)  cells were labeled with 
Na2S1CrO4 for 90 rain. Incubation of 103 labeled target cells/well 
for 1 h at 37~  with the HPLC fractions to be tested for the pres- 
ence of antigenic peptide activity preceded the addition of 104 
effector  cells/well. For the quantification of the antigenicity of the 
HPLC fractions, 10-fold dilution steps were performed. All frac- 
tions were tested in triplicates in a 3-h cytolytic assay￿9 
Results 
IFN-'y Induces an Exchange of  Proteasome Subunits in Mouse 
Fibroblast Cells.  The synthesis of both 3-type proteasome 
subunits LMP2 and LMP7 is inducible by IFN-3'. This was 
taken as an indication that proteasomes may be involved in 
the cytoplasmic processing of antigens presented by MHC 
class I molecules (22, 23). So far our knowledge about LMP2 
and LMP7 and the effect of IFN-y on proteasome composi- 
tion is solely based on immunoprecipitation of pulse-labeled 
proteasome subunits from unfractioned  cell lysates. There exists 
no information on the consequences  of the incorporation of 
these subunits into 20S proteasomes and the effect of IFN-3, 
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To analyze the effect of IFN-3' on the steady state protein 
subunit  composition of the enzyme complex,  purified 20S 
proteasomes of IFN-3~ (-) and IFN-'y (+) mouse fibroblast 
cells were applied to analysis by two-dimensional PAGE (Fig. 
1, A  and B). Comparison of the resulting Coomassie-stained 
protein subunit patterns demonstrates that stimulation of B7 
fibroblast cells with  20  U/ml  of IFN-3~ for  72 h  leads  to 
significant  alterations  in  the  steady state subunit  composi- 
tion of 20S proteasomes.  Three proteasome proteins are affected 
predominantly.  Striking  is the almost  complete absence of 
the constitutive H-type subunit  di and the concomitant  in- 
corporation of the MHC-encoded LMP2 subunit. While the 
LMP2 subunit is hardly detectable in proteasome complexes 
of nonstimulated  cells,  after cytokine stimulation  LMP2 is 
incorporated into the 20S particle at an almost equal molar 
ratio. Both subunit 5 and LMP2 exhibit amino acid sequence 
identity of close to 60%  in humans  (18,  34) and therefore 
may represent homologous subunits with related functional 
properties  within  the 20S multienzyme  complex.  In  addi- 
tion to subunit 5, the relative amount of a not yet character- 
ized 27.5-kD  subunit  is also drastically reduced and paral- 
lded  by the  appearance  of a  not  yet  characterized  27-kD 
protein.  IFN-'y  stimulation  of mouse  fibroblast  cells  also 
influences the posttranslational modification in that a reduc- 
tion in the acidic modifications of the 32-kD MC2 or-type 
subunit  is observed. 
Figure  1.  Effects  of  IFN-"/stimulation on the steady  state  subunit com- 
position of  purified 20S proteasomes.  20S proteasomes  were  biochemically 
purified from IFN-3' stimulated (20 U/ml) for 72 h and nonstimulated 
mouse fibroblast  cells. The effect  of the cytokine  on the steady state pro- 
tein composition of 20S proteasomes  was monitored  by two-dimensional 
gel electrophoretic  analysis. Separated  proteins  were  stained  with Coomassie 
brilliant blue. (A) Protein pattern of 20S proteasomes  from nonstimulated 
fibroblast  cells. The arrows  mark the subunits MC2, LMP7, tS, and LMP2; 
the triangular  arrows mark the 27.5- and 27-kD proteins. The identity of 
subunits LMP2  and LMP7  was confirmed  by immunoblotting with subunit 
specific  antibodies (35). (B) Protein pattern of20S  proteasomes  from stimu- 
lated fibroblast cells. Note that the t5 subunit is strongly reduced while 
levels of LMP7 are almost unchanged. 
In contrast to LMP2, the LMP7 protein subunit turns out 
to be a stable component of the 20S proteasome (Fig.  1, A 
and B, arrows). Moreover, despite the fact that the transcrip- 
tion of the LMP7 gene is inducible by IFN-3, (35) the rela- 
tive stoichiometric quantities of this subunit in the 20S pro- 
teasome complex is apparently not  significantly influenced 
by the  cytokine. 
IFN-9/ Influences the Chymotrypsin-like  Activity of 20S Pro- 
teasomes.  Since secondary modifications or even the exchange 
of subunits in multienzyme complexes often result in changes 
of the enzymatic properties,  we studied in more detail the 
effect of IFN-',/on the enzyme activities of the purified 20S 
proteasomes in vitro. The chymotrypsin- and trypsin-like ac- 
tivities of 20S proteasomes from IFN-3' (+) and IFN-3, (-) 
cells were assayed using standard fluorogenic peptide substrates. 
As shown in Fig.  2 A  IFN-'y stimulation  has  no apparent 
effect on the trypsin-like activity of 20S proteasomes as moni- 
tored with Bz-VGR-MCA and therefore this activity could 
serve as an additional internal activity standard.  In contrast, 
with  the  peptide  substrate  Suc-LLVY-MCA  a  dramatic 
60-70% reduction in the chymotrypsin-like peptide hydro- 
lyzing activity is observed for proteasome complexes from 
IFN-3,  stimulated  fibroblast cells  (Fig.  2 B).  As  shown in 
Fig. 2 IFN-y stimulation of fibroblast cells negatively modu- 
lates the Vm~x of the chymotrypsin-like  active site(s)  moni- 
tored with Suc-LLVY-MCA whereas no significant effect on 
the  affinity for the peptide  substrate  as determined by Km 
values is detectable (Fig.  2).  The minor chymotrypsin-like 
activity monitored  with  Suc-AAF-MCA  is not  influenced 
by stimulation of the cells with the cytokine and may indi- 
cate the presence of a separate chymotrypsin-like active site 
(data  not  shown). 
20S Proteasomes Reveal Altered Cleavage Site Preferences after 
IFN-9" Stimulation.  Fluorogenic peptide substrates are suit- 
able to characterize different proteolytically active sites of la- 
tent and active 20S proteasomes. Yet,  they provide little in- 
formation  on how proteasomes  act  on larger  polypeptides 
that  are  thought  to represent  substrates  in vivo.  To inves- 
tigate the effect of IFN-3'  on the hydrolysis of larger  sub- 
strates by 20S proteasomes in vitro we used a synthetic 25- 
mer polypeptide whose sequence was derived from the MCMV 
IE pp89 protein and that harbors the antigenic nonamer pep- 
tide of IE pp89 (31). The 25-mer polypeptide is not cleaved 
by latent 20S proteasomes (data not shown) and thus shares 
in this respect characteristics with larger protein substrates. 
For analysis the cleavage products of the 25-mer polypeptide 
obtained after incubation with purified 20S proteasome com- 
plexes from IFN-3' (-)  and IFN-3' (+) cells were separated 
by HPLC chromatography.  As shown in Fig.  3 a complete 
turnover of the pp89 25-mer polypeptide substrate is obtained 
under the incubation conditions used. Furthermore,  since no 
change in the profiles of the chromatographs  was observed 
even after prolonged 48-h incubation periods (data not shown) 
we conclude that we monitor the final digestions products 
and that observed differences are not due to incomplete hy- 
drolysis of the  used 25-mer  polypeptide substrate. 
Comparison of the chromatographs demonstrates that the 
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Figure 2.  Influence of IFN-'-/on the enzyme activity of 20S protea- 
somes. 20S proteasomes were purified to homogeneity from IFN-3' (-) 
and IFN-'y (+) mouse fibroblast cells. The enzyme kinetics for the trypsin- 
like and chymotrypsin-like peptide hydrolyzing activity were assayed  using 
the fluorogenic  substrates Bz-VGR-MCA (trypsin-like) and Suc-LLVY- 
MCA (chymotrypsin-like).  (.4) The kinetics of the trypsin-like activity. 
Vmax values: 320 pmol/100 ng proteasome per h and 280 pmol/100 ng 
after IFN-~/treatment. Km for both kinetics, 64 #M. (B) The kinetics 
of the chymotrypsin-like activity. Vm~, values: 296 pmol/100 ng protea- 
some per h and 88 pmol/100 ng proteasome after IFN-y treatment.  Km 
for both kinetics, 18/zM.  IFN-3' stimulation reduces the chymotrypsin- 
like activity of 20S proteasomes by '~60%. The kinetics shown are repre- 
sentative examples of three independent experiments. 
reduction in the chymotrypsin-like activity of 20S protea- 
somes from IFN-'y stimulated fibroblast cells is paralleled by 
an alteration in the relative amounts of specific 25-mer cleavage 
products.  In vitro digests with 20S proteasome complexes 
from IFN-y (+) cells generates several pp89 25-met cleavage 
products that were hardly detectable after digestion with pro- 
teasomes from IFN-'y (-) control cells (Fig.  3, A  and B, 
arrows). This can be due to  a change in the cleavage  site 
specificity of 20S proteasomes or that IFN-3~ stimulation in- 
duces a change in the preference at which 20S proteasomes 
use the same cleavage  sites  ot? the 25-mer polypeptide. 
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Figure 3.  Analysis  of the poly- 
peptide deavage properties of 20S 
proteasome  from  IFN-'y stimu- 
lated  and nonstimulated mouse 
fibroblast cells. For the analysis  of 
the polypeptide cleavage proper- 
ties of 20S proteasome complexes 
from IFN-"/stimulated and non- 
stimulated fibroblast cells a syn- 
thetic 25-mer polypeptide whose 
sequence was  derived from  the 
pp89 IE protein of the murine cy- 
tomegalovirus was used. 20/xg of 
substrate were incubated in the 
presence of 1 ttg proteasome at 
37~  for 24 h and the cleavage 
products  were  separated by re- 
versed  HPI.C  chromatography. 
(A)  Cleavage pattern  obtained 
with 20S proteasome from non- 
stimulated cells. (B) Cleavage  pat- 
tern obtained  with 20S protea- 
some  from  IFN-'y-stimulated 
cells. (C) Digestion of the 25-mer 
substrate in buffer in the absence 
of 20S proteasome. 
To distinguish between these activities, the pp89 25-met 
digests were subjected to aa sequence analysis by Edman degra- 
dation. Six important cleavage sites were observed within the 
25-mer polypeptide: the trypsin-like cleavage site between 
K and R and the chymotrypsin-like cleavage sites behind L, 
Y, and V. Four of these cleavage sites that are important in 
this context are shown in Fig. 4.  Of the cleavage sites de- 
tected those between L/M, Y/D, Y/P, and L/G were subject 
to alterations when proteasomes from IFN-'y stimulated cells 
were used (Figs.  4 and 5). As shown in Fig.  4 20S protea- 
some of IFN-'y (-) cells preferentially cleave the pp89 25- 
mer polypeptide between Y/P, a cleavage site that destroys 
the antigenic peptide. Remarkably, the same cleavage site is 
less frequently used by 20S proteasomes of IFN-3' (+) cells. 
In addition, proteasomes from stimulated fibroblast cells pref- 
erentially cleave between Y/D and between L/G.  It is im- 
portant to note that 20S proteasome complexes from both 
IFN-'y (-) and IFN-'y (+) fibroblast cells use the cleavage 
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Figure 4.  Modulation of the 20S proteasome by IFN-  3' results in longer 
peptides processed from the pp89 25-mer  polypeptide by altered prefer- 
ence for proteolytic cleavage sites. After digestion of the pp89 25-mer poly- 
peptide by 20S proteasomes  from IFN-3' (-) and IFN-y (+) cells, the 
peptide mixture was applied to Edman sequencing  and the summary of 
the evaluation  of the complex chromatograms is given for the aa F, E, 
and V: each of them present only once in the pp89 25-mer (data summary 
D). (A) Proteasomes from IFN-  7  (-) cells preferentially use the cleavage 
site between Y and P indicated by F in cycle 3. Proteasomes from IFN-3' 
(+) cells mainly cleave the 25-mer polypeptide between Y  and D  indi- 
cated by F in the cycle 6.  In contrast to untreated proteasomes,  longer 
peptides are derived from the 25-mer polypeptide  because there is no major 
cleavage site at an earlier position, between position 5 and 10 (no strong 
signal of F in cycles 1-5). (B) A strong signal for E in sequence cycle 4 
indicates that a major number of peptides start with G. Thus, there exists 
a major cleavage site between L and G that is even more effectively used 
by IFN-'y (+) proteasomes.  (C) V  detected in cycle 2 and 7 indicates a 
trypsin-like cleavage site between K and R  and again between L and G, 
respectively. (D) Sequence of the pp89 25-mer polypeptide. The antigenic 
nonamer is indicated by capital  letters.  The major cleavage sites identified 
by Edman degradation are indicated by arrows. The thickness of the arrows 
reflects the relative usage of the respective cleavage sites. The relative usage 
of the cleavage between L/M and WY is not shown. 
site between L and G  that generates  the correct carboxy- 
terminal residue of the antigenic pp89 nonamer at a similar 
frequency. In contrast, the cleavage site within the antigenic 
nonamer region (Y/P) is used at a strongly reduced frequency 
by 20S proteasomes of stimulated cells. This results in pep- 
tides that are longer at the amino terminus and that encompass 
the complete antigenic nonamer sequence. Thus, the cleavage 
specificity of 20S proteasomes is not changed, but IFN-'y stim- 
ulation alters the frequency at which specific cleavage sites 
of the substrate are recognized by 20S proteasome complexes. 
As a result, the quality of the peptide population generated 
is altered. 
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Figure  5.  Cleavage site usage of 20S proteasome from IFN-~/(-) and 
IFN-')' (+) cells. The graph summarizes the 20S proteasome cleavage sites 
within the pp89 25-mer polypeptide as determined by Edman degrada- 
tion.  Thick  arrows indicate increased cleavage frequencies. 
20S Proteasorne Generates a Finally Processed Nonapeptide In 
Vitro.  To test the potential antigenicity of the cleavage prod- 
ucts generated, pp89 25-mer polypeptide was digested in vitro 
by 20S proteasomes from IFN-'y (-) and IFN-3' (+) fibro- 
blast cells. Digests were separated by reverse-phase  HPLC chro- 
matography and individual fractions were assayed with pp89- 
specific CTL for antigenic peptide activity. As demonstrated 
in Fig. 6 A, 20S proteasomes of both IFN-y (+) and IFN-'/ 
(-)  cells produce peptides that bind to H-2L  d and induce 
specific CTL recognition. As a control, pp89 25-mer poly- 
peptides incubated in assays without proteasomes contained 
no antigenic peptide activities.  One of the peptides gener- 
ated exhibits a chromatographic behavior identical with that 
of the synthetic nonapeptide YPHFMPTNL, which represents 
the naturally processed pp89 peptide (32) and coelutes in frac- 
tion 40/41 of the HPLC system used. The determination of 
the cleavage site usage of the pp89 25-mer polypeptide did 
not predict the antigenic nonapeptide as a major product. 
Consistently, serial dilution of fractions 40/41 revealed an 
~l,000-fold smaller amount of the nonapeptide compared 
with the abundant cleavage products that could be identified 
by sequencing and HPLC separation (Fig.  6 B). However, 
no significant  differences were observed between digests of 
20S proteasomes from IFN-~/(-) and IFN-y (+) cells. From 
these data we conclude that the 20S proteasome possesses an 
IFN-y independent capacity to generate the antigenic non- 
apeptide. 
Discussion 
MHC class I molecules present viral antigens as peptides 
at the cell surface and IFN-'y increases the number of presented 
peptides. Therefore, one prediction for 20S proteasome func- 
tion within the MHC class 1-restricted immune response is 
that IFN-y stimulation of antigen-presenting  cells should also 
affect proteasomal enzyme activity.  Our analysis of mouse 
fibroblast  20S proteasomes demonstrates that this is indeed 
the case. IFN-y stimulation of fibroblast cells results in a down- 
regulation of the chymotrypsin-like  activity without affecting 
the trypsin-like activity. As shown by enzyme kinetics, this 
reduction in chymotrypsin-like peptide hydrolyzing activity 
is due to an impairment of the turnover rate (Vm~x) at the 
chymotrypsin-like site(s), whereas the affinity for the fluoro- 
genic peptide substrate (Km)  appears to be unchanged. 
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Figure  6.  Processing  and yield  of  antigenic  nonapeptide  by 20S protea- 
somes. (/t) pp89 25-mer polypeptide  was digested  in buffer  only  (control), 
with 20S proteasomes  prepared from  either  normal (IFN-3' (-)) or IFN-3' 
(20 U/ml for 72 h)-pretreated (IFN-y (+)) fibroblast cells and cleavage 
products were separated  by reverse-phase  HPLC. Individual  fractions  were 
tested in triplicate  for their  content  of  antigenic  peptide  with  YPHFMPTNb 
specific polyclonal  CTLs. Fractions  with major biological  activity  are in- 
dicated. For comparison, the elution  profile  of the synthetic  nonamer  and 
the biological activity of the synthetic peptide at a concentration of 
10 -9 M is shown. (B) The biological  activity  that was detected  in frac- 
tions  40/41 corresponding  to  the  elution  of  the  nonapeptide 
YPHFMPTNL were quantified  by testing log10 dilutions  in the slCr re- 
lease assay. Squares indicate  the titration of the respective fractions  of the 
IFN-3' (+) digest, circles indicate  dilution  of the IFN-'y  (-) digest. The 
peptide concentration of pooled fractions 40 and 41 was determined to 
be 1.4  x  10- 7 M. An equivalent  concentration  of YPHFMPTNL was 
titrated in logt0 steps and tested in the cytolytic  assay (triangles). 
This cytokine dependent effect on the chymotrypsin-like 
activity of 20S proteasomes is paralleled  by an alteration in 
the steady state protein subunit composition of 20S protea- 
somes. The most obvious change concerns the enhanced in- 
corporation of the LMP2 protein to stoichiometric amounts 
into the 20S proteasome complex. In addition, we observed 
the incorporation of a not yet characterized 27-kD subunit. 
The same protein is also a constitutive subunit of mouse liver 
20S proteasomes isolated from nonstimulated mice.  There- 
fore, its presence is probably not the result of a primary IFN-3' 
response. 
The rapid incorporation of the LMP2 subunit into the 20S 
enzyme complex appears to take place simultaneously with 
the decrease of the highly related/5-type ~ proteasome subunit. 
It is not yet proven whether this finding reflects a replace- 
ment. However, our studies using transfected human T2 cell 
lines that constitutively express the LMP2 subunit show that 
the 20S proteasomes in these cells lack the ~ subunit (35a). 
Several/5-type subunits influence the activity of  chymotrypsin- 
like active sites (12, 36). Therefore, it is reasonable to assume 
that the replacement of subunit ~ by LMP2 contributes to 
the down regulation of the chymotrypsin-like activity of the 
enzyme complex. Both LMP2 and subunit ~ possess exten- 
sive sequence homologies to the/5 subunit of the thermoplasma 
20S proteasome which creates the single chymotrypsin-like 
activity of the complex (12, 36). Finally, Wolf et al. (11) re- 
cently showed that the yeast proteasome PRE-2 subunit is 
homologous to LMP7 and, based on this observation, they 
already discussed the possibility that the constitutive ~ subunit 
may be replaced  by LMP2 upon IFN-3' induction. 
IFN-3, does not significantly influence the half life of 20S 
proteasomes (35a). Therefore, the rapid incorporation ofequi- 
molar amounts of LMP2 protein into 20S proteasomes and 
the replacement of the ~ subunit must, to a large extent, take 
place in preexisting cytosolic 20S proteasomes and can not 
be explained by de novo synthesis of proteasomes.  Altera- 
tions in proteasome subunit composition have been observed 
before during development (37). Therefore, the substitution 
of subunits may represent a mechanism to adapt proteasome 
function to changing physiological requirements. 
In contrast to LMP2, the related LMP7 subunit is a con- 
stitutive component of B7 fibroblast  20S proteasomes and 
its  incorporation  into  the  complex  is  not  significantly 
influenced by IFN-3,. The constitutive presence of LMP7 may 
be cell line specific since it is not observed in human cell lines 
where the incorporation of  both subunits is strongly enhanced 
after IFN-3' stimulation (22,  23). 
IFN-'~ mediates the reduction of the chymotrypsin-like pep- 
tide hydrolyzing activity as determined by fluorogenic pep- 
tide substrates. The longer peptide substrate (25 met) demon- 
strates a change in the frequency at which specific cleavage 
sites within the MCMV pp89 25-met polypeptide are used. 
This divergence of cleavage activity detected by long and short 
substrates indicates to us that peptide configuration may con- 
tribute to proteasome function. In this context it should be 
recollected that the latent proteasome, i.e,, proteasomes that 
possess peptide hydrolyzing  activity but can not cleave larger 
substrates,  cleaves the short peptides but not at all the longer 
25-mer polypeptide. Thus, both assays detect different quali- 
ties of the proteasome. IFN-y activation results in the produc- 
tion of a different set of peptides.  However, it is important 
906  IFN-'y Modulates Proteasome Activity to emphasize that IFN-3' stimulation does not generate new 
cleavage site specificities and thus the intrinsic enzymatic prop- 
erties of the enzyme complex remain preserved. 
The 25-mer polypeptide delineated from the IE pp89 of 
MCMV used in these studies contains the nonapeptide se- 
quence YPHFMPTNL which represents the naturally pro- 
cessed dominant antigenic peptide that is presented by the 
MHC class I molecule L d. Ld-restricted CTLs with specifi- 
city for this peptide were used to monitor the generation 
of biological activity. Its identity with the synthetic nonapep- 
tide was tested by the elution profile of the activity in the 
HPLC. The in vitro studies indicate that both preparations, 
20S proteasomes from normal and from IFN-y-induced cells, 
are able to generate a minor biological activity that is indis- 
tinguishable from the synthetic peptide. If such peptides get 
access to transporter functions they provide a basic level of 
peptide presentation that is consistent with the observation 
that antigen presentation by a cell lacking both the TAP and 
the LMP genes can be achieved by reconstitution of only the 
TAP genes (26,  27). 
The LMP genes are inducible by IFN-y and if they con- 
tribute to antigen processing, the cleavage products from 20S 
proteasomes of IFN-3'-induced cells should show this poten- 
tial. Our observation that proteasomes from IFN-y (+) cells 
did not produce more biological activity in vitro, as detect- 
able by CTLs, demonstrates that IFN-3' does not activate the 
proteasome directly to produce the final peptide. However, 
proteasome complexes from IFN-3~ (+) cell produce a quali- 
tatively different set of peptides. 
These conclusions are based on the following result. Al- 
ready in the absence of IFN-3', but even more so after IFN-3' 
induction, the carboxy-terminal leucine residue of the non- 
apeptide represents a major cleavage site. To cleave after basic 
or hydrophobic residues is a general functional property of 
20S  proteasomes  (see  also  above).  Therefore,  the  precise 
cleavage behind such residues could provide a transport signal 
and contribute to the observation that many carboxy-terminal 
residues in naturally found antigenic peptides share this prop- 
erty (38). 
Testing of short substrates reveals an overall  decrease of 
the chymotrypsin-like activity after IFN-3' induction. Testing 
of the 25-met polypeptide provides the additional informa- 
tion of a selective and differential usage of the chymotrypsin- 
like cleavage sites. Without IFN-y the position between Tyr 
and Pro represented a major cleavage signal that is associated 
with a loss of the amino-terminal Y of the nonapeptide, and 
in consequence with  the loss  of antigenic activity of the 
resulting  peptides  (32,  39).  20S  proteasomes  from  IFN- 
~'-treated cells cleave at a more distant site leaving the nonamer 
intact. This 11-mer polypeptide is generated in vitro as a major 
fraction sufficient for direct isolation and sequencing (data 
not shown). Yet, without further amino-terminal trimming 
this ll-mer polypeptide has little activity (32). Thus, the reduc- 
tion of cleavage sites results in the generation of longer pep- 
tides that have the potential to be converted to biologically 
active shorter peptides. Whether this represents a general prin- 
ciple has to be shown using additional polypeptide substrates. 
Based on our data we hypothesize that it is the IFN-y-de- 
pendent function of the LMP genes to contribute to the gener- 
ation of different and larger pools of precursor peptides. Ac- 
cordingly, the loss of one or both genes would not destroy 
peptide presentation but reduce the potential diversity of the 
peptide pool. The generation of longer peptides requires fur- 
ther degradation in the cytosol or the endoplasmic reticulum. 
If, as in the example tested here, only amino-terminal trim- 
ming is required, the trimming could occur even at the MHC 
I molecule itself, as has been suggested earlier (38). 
During revision of this manuscript two papers on related 
topics have been published (40, 41). In essence, these papers 
also describe a difference in peptide cleavage activity of short 
fluorogenic substrates by IFN-3,-activated  proteasomes. Differ- 
ently from us,  both  groups  report  on an  increase in  the 
chymotrypsin-like and trypsin-like activity. First, in contrast 
to the fibroblast used in this study, these authors studied hepa- 
toma cells and lymphoid cell lines. Second, the IFN-y induc- 
tion protocols of 1,000  U/ml for 3 d  (41) or 20 U/ml for 
14 d (40), respectively, differ significantly from our protocol 
of 20 U/ml for 3 d  that was aimed to reflect more closely 
the conditions found in vivo. In this context it is worth noting 
that the more vigorous induction protocol (41) also led to 
a similar increase in enzyme activity even in the MHC-deficient 
712.174 cells that lack LMP2 and LMP7 altogether. Finally, 
in agreement to our polypeptide data, the latter authors also 
found that cleavage of fluorogenic substrates does not reflect 
the activity on protein substrates. The effect on larger pep- 
tides and proteins was not further studied. 
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